The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial).
 
Axel Nelson
No Relationships to Disclose
 
Amir Shafazand
Employment - ICON Clinical Research
 
Christian Cahlin
Stock and Other Ownership Interests - Hansa Biopharma; Hansa Biopharma (I)
 
Ana Carneiro
Honoraria - BMSi; Pierre Fabre
Consulting or Advisory Role - Baxter; Merck (Inst); MSD; Novartis; Pierre Fabre; Transgene (Inst)
Expert Testimony - BMSi; Merck
 
Hildur Helgadottir
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre
Consulting or Advisory Role - MSD; Novartis
 
Max Levin
No Relationships to Disclose
 
Magnus Rizell
No Relationships to Disclose
 
Gustav J. Ullenhag
Stock and Other Ownership Interests - Essity; Oncopeptides
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb; Incyte; Lidds; MSD; Novartis; SeqCure Immunology
 
Sara Wirén
No Relationships to Disclose
 
Per Lindner
Consulting or Advisory Role - Pierre Fabre
 
Jonas A Nilsson
Stock and Other Ownership Interests - SATMEG Ventures AB
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; LEO Pharma; Miltenyi Biotec; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)